0001209191-15-007219.txt : 20150128
0001209191-15-007219.hdr.sgml : 20150128
20150128201008
ACCESSION NUMBER: 0001209191-15-007219
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150126
FILED AS OF DATE: 20150128
DATE AS OF CHANGE: 20150128
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDTRONIC INC
CENTRAL INDEX KEY: 0000064670
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 410793183
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0425
BUSINESS ADDRESS:
STREET 1: 710 MEDTRONIC PKWY
STREET 2: MS LC300
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55432
BUSINESS PHONE: 7635144000
MAIL ADDRESS:
STREET 1: 710 MEDTRONIC PKWY
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55432
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Powell Kendall J
CENTRAL INDEX KEY: 0001298823
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-07707
FILM NUMBER: 15556518
MAIL ADDRESS:
STREET 1: ONE GENERAL MILLS BLVD
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55426
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-01-26
1
0000064670
MEDTRONIC INC
MDT
0001298823
Powell Kendall J
GENERAL MILLS,
ONE GENERAL MILLS BLVD
MINNEAPOLIS
MN
55426
1
0
0
0
Common stock
2015-01-26
4
D
0
19601.464
D
0
D
Common stock
2015-01-26
4
D
0
3000
D
0
I
By Spouse Rev Trust
Stock option (right to buy)
51.61
2015-01-26
4
D
0
2713
D
2017-06-22
Common stock
2713
0
D
Stock option (right to buy)
51.61
2015-01-26
4
D
0
264
D
2017-06-22
Common stock
264
0
D
Stock option (right to buy)
52.84
2015-01-26
4
D
0
1010
D
2017-09-01
Common stock
1010
0
D
Stock option (right to buy)
50.34
2015-01-26
4
D
0
1590
D
2018-04-28
Common stock
1590
0
D
Stock option (right to buy)
29.96
2015-01-26
4
D
0
2671
D
2019-04-27
Common stock
2671
0
D
Stock option (right to buy)
44.13
2015-01-26
4
D
0
1813
D
2020-05-03
Common stock
1813
0
D
Represents shares of Medtronic, Inc. ("Medtronic"), including deferred units credited under a Medtronic, Inc. equity-based plan to be paid in Medtronic, Inc. common stock upon the director's resignation or retirement as well as a balance increase of 3,263.44 shares since the director's last Form 4 filing due to exempt transactions such as dividend reinvestment, disposed of pursuant to the merger (the "Merger)of a wholly-owned subsidiary of Medtronic plc ("New Medtronic") with and into Medtronic, with Medtronic surviving as a wholly-owned subsidiary of New Medtronic, in exchange for ordinary shares of New Medtronic, which was consummated after and conditioned on New Medtronic's acquisition of Covidien plc, by means of a "scheme of arrangement", an Irish statutory procedure under the Companies Act of 1963. At the effective time of the Merger, each Medtronic common share (including each deferred unit) was cancelled and converted into the right to receive one New Medtronic ordinary share.
This option, which was fully vested at the effective time of the Merger, was assumed by New Medtronic in the Merger and converted into an option to purchase 2,713 ordinary shares of New Medtronic for $51.61 per share with the same terms and conditions as the original Medtronic stock option.
This option, which was fully vested at the effective time of the Merger, was assumed by New Medtronic in the Merger and converted into an option to purchase 264 ordinary shares of New Medtronic for $51.61 per share with the same terms and conditions as the original Medtronic stock option.
This option, which was fully vested at the effective time of the Merger, was assumed by New Medtronic in the Merger and converted into an option to purchase 1,010 ordinary shares of New Medtronic for $52.84 per share with the same terms and conditions as the original Medtronic stock option.
This option, which was fully vested at the effective time of the Merger, was assumed by New Medtronic in the Merger and converted into an option to purchase 1,590 ordinary shares of New Medtronic for $50.34 per share with the same terms and conditions as the original Medtronic stock option.
This option, which was fully vested at the effective time of the Merger, was assumed by New Medtronic in the Merger and converted into an option to purchase 2,671 ordinary shares of New Medtronic for $29.96 per share with the same terms and conditions as the original Medtronic stock option.
This option, which was fully vested at the effective time of the Merger, was assumed by New Medtronic in the Merger and converted into an option to purchase 1,813 ordinary shares of New Medtronic for $44.13 per share with the same terms and conditions as the original Medtronic stock option.
/s/ Rhonda L. Ingalsbe, Attorney-in-fact
2015-01-28